Results 181 to 190 of about 41,151 (199)

Pharmacokinetics of Levodopa

Clinical Neuropharmacology, 1984
J H Fellman, John G. Nutt
openaire   +2 more sources

Antagonism of Levodopa by Papaverine

JAMA: The Journal of the American Medical Association, 1975
PAPAVERINE, the isoquinoline alkaloid, is widely employed in various formulations in the treatment of patients believed to be suffering from cerebral arteriosclerosis. Patients with Parkinson disease may thus be given papaverine preparations when symptoms are suggestive of cerebral vascular insufficiency or appear to represent instances of ...
openaire   +3 more sources

Levodopa

Annals of Internal Medicine, 1971
openaire   +2 more sources

Levodopa in Parkinsonism

Drugs, 1971
T. N. Chase, J. L. Weiss
openaire   +3 more sources

Levodopa

2007
Thomas D, Hälbig, William C, Koller
openaire   +2 more sources

Levodopa and survival

Neurology, 1994
Elizabeth J. Atkinson, P. C. O'Brien, Manfred D. Muenter, J. E. Ahlskog, Demetrius M. Maraganore, Ryan J. Uitti, Ruth H. Cha   +6 more
openaire   +3 more sources

Levodopa for Parkinsonism

Anesthesiology, 1971
openaire   +3 more sources

LEVODOPA IN VITILIGO

The Lancet, 1973
openaire   +3 more sources

Is Levodopa Toxic?

Archives of Neurology, 2000
openaire   +3 more sources

Is levodopa harmful?

The Lancet, 1991
T. Tacke, N. Arts, C. Van De Vlasakker, Martin W.I.M. Horstink   +3 more
openaire   +3 more sources